JG
LXRX icon

Jefferies Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jefferies Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-43,852
Closed -$182K – 2423
2019
Q4 		$182K Buy
+43,852
New +$169K ﹤0.01% 2280
2017
Q3 		– Sell
-16,593
Closed -$273K – 2524
2017
Q2 		$273K Buy
+16,593
New +$257K 0.01% 1909
2015
Q2 		– Sell
-28,545
Closed -$188K – 3445
2015
Q1 		$188K Buy
28,545
+25,198
+753% +$172K ﹤0.01% 1779
2014
Q4 		$21K Buy
+3,347
New +$27K ﹤0.01% 1868
2014
Q1 		– Sell
-303,663
Closed -$3.81M – 2254
2013
Q4 		$3.81M Buy
303,663
+301,866
+16,798% +$4.8M 0.16% 381
2013
Q3 		$30K Buy
+1,797
New +$30.1K ﹤0.01% 1806

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.6B AUM 47.77% 1-Year Est. Return